NBAS: A Potential Drug Target for Neurological Disorders (G51594)

Target Name: NBAS

NCBI ID: G51594

NBAS

NBAS: A Potential Drug Target for Neurological Disorders

NBAS, or N-Acetyl-L-Aspartate (NAA), is a subunit of the neurotransmitter acetylcholine, which is involved in memory and cognitive processes. NBAS has been identified as a potential drug target for the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic insomnia.

TheNRZ tethering complex is a protein complex that is involved in the regulation of neurotransmitter release in the nervous system. This complex is composed of multiple subunits, including NBAS, which is known for its role in the regulation of neurotransmitter acetylcholine (Acetylcholine) release.

Research has shown that NBAS is involved in the regulation of acetylcholine release from the NRZ terminal (neuron terminal) of the NRZ tethering complex. This is important for the normal function of the nervous system, as acetylcholine is involved in the transmission of signals in the brain . NBAS has been shown to play a role in the regulation of neurotransmitter release from the NRZ terminal, and may be a useful drug target for the treatment of neurological disorders.

In addition to its role in the regulation of neurotransmitter release, NBAS has also been shown to play a role in the regulation of protein synthesis and may be involved in the development of neurodegenerative diseases.

NBAS has been shown to play a role in the regulation of neurotransmitter release from the NRZ terminal of the NRZ tethering complex. This is important for the normal function of the nervous system, as acetylcholine is involved in the transmission of signals in the brain.

Research has shown that NBAS is involved in the regulation of acetylcholine release from theNRZ terminal of theNRZ tethering complex. This is important for the normal function of the nervous system, as acetylcholine is involved in the transmission of signals in the brain. NBAS has been shown to play a role in the regulation of neurotransmitter release from the NRZ terminal, and may be a useful drug target for the treatment of neurological disorders.

In addition to its role in the regulation of neurotransmitter release, NBAS has also been shown to play a role in the regulation of protein synthesis and may be involved in the development of neurodegenerative diseases.

NBAS has been shown to play a role in the regulation of neurotransmitter release from the NRZ terminal of the NRZ tethering complex. This is important for the normal function of the nervous system, as acetylcholine is involved in the transmission of signals in the brain.

Research has also shown that NBAS is involved in the regulation of the stability of theNRZ tethering complex, which is composed of multiple subunits including NBAS. This suggests that NBAS may play a role in the regulation of neurotransmitter release from theNRZ terminal of theNRZ tethering complex and may be a useful target for the development of new treatments for neurological disorders.

In conclusion, NBAS is a subunit of the NRZ tethering complex that is involved in the regulation of neurotransmitter release from the NRZ terminal. This is important for the normal function of the nervous system and may be a useful drug target for the treatment of neurological disorders. Further research is needed to fully understand the role of NBAS in the regulation of neurotransmitter release and the development of neurodegenerative diseases.

Protein Name: NBAS Subunit Of NRZ Tethering Complex

Functions: Involved in Golgi-to-endoplasmic reticulum (ER) retrograde transport; the function is proposed to depend on its association in the NRZ complex which is believed to play a role in SNARE assembly at the ER (PubMed:19369418). Required for normal embryonic development (By similarity). May play a role in the nonsense-mediated decay pathway of mRNAs containing premature stop codons (By similarity)

The "NBAS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NBAS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets